|
|
|
|
Vol. 61, Issue 3, 569-577, March 2002
Department of Pharmacology and the Lineberger Comprehensive Cancer
Center, University of North Carolina, Chapel Hill, North Carolina
(M.H., P.K., M.C., Y.W., L.M.G.); and Department of Pharmacology, Duke
University, Durham, North Carolina (T.A.H.)
Carbamoyl phosphate synthetase II (CPSII) is part of carbamoyl
phosphate synthetase/aspartate transcarbamoylase/dihydroorotase (CAD),
a multienzymatic protein required for the de novo synthesis of
pyrimidine nucleotides and cell growth. Herein, we identify CAD as a
substrate for caspase-3 degradation in both in vitro and in vivo models
of apoptosis. Withdrawal of interleukin-3 or incubation with
staurosporine (STS) or doxorubicin (Dox) resulted in proteolytic
cleavage of CAD in a myeloid precursor cell line (32D) or in a cell
line over-expressing CAD. The rapid decline in the CPSII activity
paralleled the degradation of CAD and preceded the appearance of
Annexin-V-stained apoptotic cells and DNA fragmentation. These events
correlated closely with the activation of caspase-3 in these cells and
were prevented by the cell-permeable caspase inhibitor
N-benzyloxycarbonyl-Asp-Glu-Val-Asp fluoromethyl ketone. Moreover, the incubation of purified CAD with recombinant caspase-3 in
vitro generated CAD fragments that were similar to those obtained in
vivo. Edman sequencing revealed that two of the major caspase-3 cleavage sites occurred at the sequences EAVD
G and VACD
G within the catalytic (B2) and allosteric (B3) domains of CAD, thus providing a
potential mechanism for the rapid inactivation of CPSII during apoptosis. Consistent with this, an enhanced loss of the intracellular pyrimidines (UTP and CTP) was observed in response to STS or
DOX-induced apoptosis. Therefore, these studies show that CAD is a
novel target for caspase-dependent regulation during apoptosis and
suggest that the selective inactivation of pyrimidine nucleotide
synthesis accompanies the process of apoptosis.
This article has been cited by other articles:
![]() |
G. B. Willer, V. M. Lee, R. G. Gregg, and B. A. Link Analysis of the Zebrafish perplexed Mutation Reveals Tissue-Specific Roles for de Novo Pyrimidine Synthesis During Development Genetics, August 1, 2005; 170(4): 1827 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Lindsey-Boltz, E. M. Wauson, L. M. Graves, and A. Sancar The human Rad9 checkpoint protein stimulates the carbamoyl phosphate synthetase activity of the multifunctional protein CAD Nucleic Acids Res., August 23, 2004; 32(15): 4524 - 4530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huang, Y. Wang, M. Collins, B. S. Mitchell, and L. M. Graves A77 1726 Induces Differentiation of Human Myeloid Leukemia K562 Cells by Depletion of Intracellular CTP Pools Mol. Pharmacol., September 1, 2002; 62(3): 463 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huang, Y. Wang, M. Collins, J. J. Gu, B. S. Mitchell, and L. M. Graves Inhibition of Nucleoside Transport by p38 MAPK Inhibitors J. Biol. Chem., August 2, 2002; 277(32): 28364 - 28367. [Abstract] [Full Text] [PDF] |
||||